These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26642877)

  • 41. Value of R2* obtained from T2*-weighted imaging in predicting the prognosis of advanced cervical squamous carcinoma treated with concurrent chemoradiotherapy.
    Li XS; Fan HX; Fang H; Song YL; Zhou CW
    J Magn Reson Imaging; 2015 Sep; 42(3):681-8. PubMed ID: 25581675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Carcinoma of the uterine cervix. I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy.
    Perez CA; Grigsby PW; Castro-Vita H; Lockett MA
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1275-88. PubMed ID: 7635767
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results.
    Vincens E; Balleyguier C; Rey A; Uzan C; Zareski E; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
    Cancer; 2008 Oct; 113(8):2158-65. PubMed ID: 18780318
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A dose-volume analysis of magnetic resonance imaging-aided high-dose-rate image-based interstitial brachytherapy for uterine cervical cancer.
    Yoshida K; Yamazaki H; Takenaka T; Kotsuma T; Yoshida M; Furuya S; Tanaka E; Uegaki T; Kuriyama K; Matsumoto H; Yamada S; Ban C
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):765-72. PubMed ID: 19836165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor and normal tissue dosimetry changes during MR-guided pulsed-dose-rate (PDR) brachytherapy for cervical cancer.
    Morgia M; Cuartero J; Walsh L; Jezioranski J; Keeler K; Xie J; Massey C; Williamson D; Cho YB; Oh S; Fyles A; Milosevic M
    Radiother Oncol; 2013 Apr; 107(1):46-51. PubMed ID: 23540555
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Magnetic resonance imaging for assessment of parametrial tumour spread and regression patterns in adaptive cervix cancer radiotherapy.
    Schmid MP; Fidarova E; Pötter R; Petric P; Bauer V; Woehs V; Georg P; Kirchheiner K; Berger D; Kirisits C; Dörr W; Dimopoulos JC
    Acta Oncol; 2013 Oct; 52(7):1384-90. PubMed ID: 23957566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of measurements of the uterus and cervix obtained by magnetic resonance and transabdominal ultrasound imaging to identify the brachytherapy target in patients with cervix cancer.
    van Dyk S; Kondalsamy-Chennakesavan S; Schneider M; Bernshaw D; Narayan K
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):860-5. PubMed ID: 24462382
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours.
    Viswanathan AN; Dimopoulos J; Kirisits C; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):491-8. PubMed ID: 17331668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapy.
    Rijkmans EC; Nout RA; Rutten IH; Ketelaars M; Neelis KJ; Laman MS; Coen VL; Gaarenstroom KN; Kroep JR; Creutzberg CL
    Gynecol Oncol; 2014 Nov; 135(2):231-8. PubMed ID: 25172763
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation of clinical and MRI staging in cervical carcinoma treated with radiation therapy: a single-center experience.
    Engin G; Küçücük S; Ölmez H; Haşıloğlu ZI; Dişçi R; Aslay I
    Diagn Interv Radiol; 2011 Mar; 17(1):44-51. PubMed ID: 20683815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-volume histogram parameters and late side effects in magnetic resonance image-guided adaptive cervical cancer brachytherapy.
    Georg P; Lang S; Dimopoulos JC; Dörr W; Sturdza AE; Berger D; Georg D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):356-62. PubMed ID: 20385450
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Entropy of T2-weighted imaging combined with apparent diffusion coefficient in prediction of uterine leiomyoma volume response after uterine artery embolization.
    Cao MQ; Suo ST; Zhang XB; Zhong YC; Zhuang ZG; Cheng JJ; Chi JC; Xu JR
    Acad Radiol; 2014 Apr; 21(4):437-44. PubMed ID: 24594413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Radiation therapy for uterine cervix cancer: importance of evaluation of pre-treatment tumor size with MR imaging].
    Sasaoka M; Nomoto Y; Shoji K; Kobayashi S; Toyota S; Nakagawa T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jul; 57(8):505-9. PubMed ID: 9267139
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined external and intracavitary irradiation in treatment of advanced cervical carcinomas: predictive factors for local tumor control and early recurrences.
    Sorbe B; Bohr L; Karlsson L; Bermark B
    Int J Oncol; 2010 Feb; 36(2):371-8. PubMed ID: 20043071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Determination of tumour regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability.
    Gong QY; Tan LT; Romaniuk CS; Jones B; Brunt JN; Roberts N
    Br J Radiol; 1999 Jan; 72(853):62-72. PubMed ID: 10341691
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Usefulness of tumor size on MR imaging in assessing the prognosis of uterine cervical cancer treated with radiation].
    Hayashi T; Kato T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 May; 59(6):250-5. PubMed ID: 10388310
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Registration of structurally dissimilar images in MRI-based brachytherapy.
    Berendsen FF; Kotte AN; de Leeuw AA; Jürgenliemk-Schulz IM; Viergever MA; Pluim JP
    Phys Med Biol; 2014 Aug; 59(15):4033-45. PubMed ID: 24990772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.